Abstract
The COVID-19 pandemic had a significant impact on endemic respiratory illnesses. Through behavioural changes in populations and government policy, mainly through non-pharmaceutical interventions (NPIs), Canada saw historic lows in the number of Influenza A cases from 2020 through 2022. In this study, we use historical influenza A data for Canada and three provincial jurisdictions within Canada: Ontario, Quebec and Alberta to quantify the effects of these NPIs on influenza A. We aim to see which base parameters and derived parameters of an SIR model are most affected by NPIs. We find that the effective population size is the main driver of change, and discuss how these retrospective estimates can be used for future forecasting.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
MB developed and analyzed the model; HM collected data and performed analysis; KM and PZ collected data.
The authors have no competing interests.
Data Availability
The data are all publicly available through Canada, Ontario, Quebec and Alberta health portals. All portals are cited in the text.
